At a time when chicken consumption is at an all time high in India, a study by Delhi non-profit Centre for Science and Environment shows poultry meat could be churning out robust microbes that can render all antibiotics ineffective
Lab study Ramakant Sahu & Poornima Saxena, Research Amit Khurana & Mouna Nagaraju reporting Ankur Paliwal & Jyotsna Singh
In 1945, after receiving the Nobel Prize for his chance discovery of miracle cure, penicillin antibiotic, Alexander Fleming issued a warning. “There is the danger that the ignorant man may easily under-dose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant,” he said. Since the discovery of penicillin, scientists have made antibiotics to cure multitudes of diseases—tuberculosis, typhoid, urinary tract infection, septicaemia, and the list goes. But Fleming’s warning continues to haunt them. More so, because antibiotics are no more restricted to humans nor limited to treating diseases. In poultry, for instance, the industry has found another use for antibiotics: as a growth promoter. Chickens are fed antibiotics so that they gain weight and grow fast.
Public health experts have long suspected that such rampant use of antibiotics could be a reason for increasing antibiotic resistance in India. But the government has no data on the use of antibiotics in the country, let alone on the prevalence of antibiotic resistance.
A recent study now confirms what has for long been suspected. Delhi non-profit Centre for Science and Environment (CSE) has found residues of antibiotics in 40 per cent of the chicken samples it tested. This suggests that the chickens were exposed to antibiotics throughout their short life cycle of 35-42 days.
The Pollution Monitoring Laboratory of CSE tested 70 chicken samples procured from 16 markets in Delhi and the National Capital Region. Three tissues—muscle, liver and kidney—were tested for the presence of six antibiotics widely used in poultry: oxytetracycline, chlortetracycline and doxycycline (from class tetracyclines);enrofloxacin and ciprofloxacin (from fluoroquinolones) and neomycin, an aminoglycoside.
Residues of five of the six antibiotics were found in the chicken samples. The antibiotic residues were detected in all the three tissues. They were in the range of 3.37-131.75 µg/kg. Of the 40 per cent samples found tainted with antibiotic residues, 22.9 per cent contained residues of only one antibiotic while the remaining 17.1 per cent samples had residues of more than one antibiotics. Liver samples contained the maximum antibiotic residue, followed by muscle and kidney tissue (see ‘Know the chicken you eat’). To understand any seasonal variation in the levels of antibiotic residues, CSE researchers conducted the study in two phases: first during September-October 2013, and then between May and June 2014.
The findings were alarming in both the phases. They suggest an indiscriminate use of antibiotics in poultry.
“Repeated and prolonged exposure to antibiotics lead, by natural selection, to the emergence of resistant strains of bacteria,” says Neil Schluger, chief scientific officer, World Lung Foundation, New York. These mutated robust strains bypass toxic effects of antibiotics, making them ineffective. They can easily spread among the flock raised in squalor and contaminate the food chain. They can also alter the genetic material of other bacteria, often pathogenic ones, making them resistant to several drugs and resulting in a global pandemic.
Humans are at a double threat. The mutated robust microbe strain can invade the body and cause diseases that are difficult to treat. Secondly, antibiotic residues present in the meat can directly unleash an assault on microbes in humans. “Residues of antibiotics present in meat can easily find their way into the human body, where they can create resistant microbes,” says RandeepGuleria, professor of pulmonary medicine at the All India Institute of Medical Sciences, Delhi (see ‘Smart moves...’).
The scale of threat can be gauged from the fact that antibiotics are frequently pumped into chicken during its life cycle: they are occasionally given as a drug to treat infections, regularly mixed with feed to promote growth and routinely administered to all birds for several days to prevent infections, even when there are no sign of it. “Finding antibiotics in chicken is worrying because several antibiotics used in poultry are also used in human beings,” Guleria adds.
To ascertain the linkage between overuse of antibiotics in poultry farms and antibiotic resistance in humans, CSE researchers reviewed 13 studies conducted by various government and private hospitals across the country between 2002 and 2013. The result was startling. Resistance was very high against ciprofloxacin, doxycycline and tetracycline. In certain studies reviewed by CSE, almost all of Pseudomonas, Enterobacter, Escherichia Coli and Klebsiella were found to be resistant to ciprofloxacin (see ‘Bacteria have become highly resistant...’).
A world outsmarted by microbes
“Resistance to antibiotics is a major crisis that is going to hit the healthcare sector soon,” says Devi Shetty, cardiac surgeon and founder of Narayana Health, a charitable hospital (see interview).
These drug-resistant bacteria could nullify the gains of modern medicine by compromising the success of organ transplants, high-end surgeries and cancer chemotherapy.
“Not long ago, I treated a patient with drug-resistant tuberculosis,” says Schluger. “What could have been a simple six month course of treatment turned into a two-year ordeal which involved drugs that damaged the patient’s hearing and nerves. Major surgery was required to remove diseased areas of his lung,” he adds.
With drugs losing their effectiveness, the world would need newer antibiotics. Unfortunately, no new class of antibiotic has hit the market since late 1980s. In the US, more than 2 million people suffer from antibiotic-resistance-related illnesses every year; 23,000 of them succumb to the diseases. Annual healthcare cost due to antibiotic resistance is estimated to be as high as $20 billion, with an additional productivity loss of up to $35 billion in the US.
No such estimates are available for India, but cases of high antibiotic resistance are emerging from across the country. VipinVashishtha, who runs Mangla Hospital in Bijnor, Uttar Pradesh, writes on the pervasiveness of antibiotic resistance in the February 2011 issue of Indian Paediatrics. Bacteria found in 14 infants at his hospital were resistant to all classes of antibiotics—cephalosporins, aminoglycosides, monobactams, quinolones, piperacillin-tazobactam combination and carbapenems. These children were administered expensive antibiotics like polymyxin B and colistin, but only eight could be saved. Four of these eight developed complications like meningitis and arthritis, he wrote (see ‘Fatal resistance,’ Down To Earth, October 16-31, 2011).
Guleria elaborates. Antibiotic resistance leads to two problems—mild infections require stronger dosage and no effective antibiotics are left for treating severe infections. Resistance to a class of antibiotics, for instance fluoroquinolone, has fatal consequences. Fluoroquinolone antibiotics are prominently used to combat infections in intensive care units. Treating fatal diseases like sepsis, pneumonia and tuberculosis (TB) are becoming tough because microbes that cause these diseases are increasingly becoming resistant to fluoroquinolones. “We are receiving reports of multi-drug-resistant TB (MDR-TB) and extreme-drug-resistant TB (XDR-TB), ” he adds.
Replying to a question in Parliament recently, Union health minister Harsh Vardhan said that the number of MDR-TB cases in the country has increased five times to 23,325 between 2011 and 2013.
“Almost one-third of all MDR-TB cases are resistant to fluoroquinolone, which forms the backbone of MDR-TB treatment,” says AnujBhatnagar, doctor at RajanBabu Institute of Pulmonary Medicine and Tuberculosis, Delhi. “These patients are just one step short of XDR-TB, at which the options of treatment are seriously limited.”
CSE study found two fluoroquinolone antibiotics—enrofloxacin and ciprofloxacin—in 28.6 per cent chicken samples tested.
“This is just a tip of the iceberg,” say CSE researchers. “We have tested chicken samples only for six widely-used antibiotics in the country. There are many more antibiotics that are routinely used in poultry.”
For example, Skylark Hatcheries, an integrated poultry company in Jind, Haryana, uses Enramycin. Venky’s uses bacitracin in its feed Bamylate, while Vetline India uses furazolidone antibiotic in its feed Furavet. Some European countries ban the use of bacitracin and furazolidone as growth promoters. Antibiotics from classes of cephalosporins, penicillins and macrolides are also among the most popular antibiotics used in poultry farms in India. WHO classifies these antibiotics as critical for human use.
Tags: Cover Story
, Animal Products
, Antibiotic Residues
, Bacterial Infections
, Bureau of Indian Standards (BIS)
, CSE Study
, Devi Shetty
, Down to earth
, European Union (EU)
, Food Standards
, Health Effects
, Micro Organisms
, Multi-Drug Resistant Bacteria
, United States Of America (US)
, Print edition